Status:
COMPLETED
A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
Lead Sponsor:
GlaxoSmithKline
Conditions:
Herpes Zoster
Eligibility:
All Genders
60+ years
Brief Summary
The study aims to estimate the incidence of herpes zoster (HZ), proportion of postherpetic neuralgia (PHN) and the economic burden and impact on quality of life, in Japanese adults greater than or equ...
Eligibility Criteria
Inclusion
- Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
- Written informed consent obtained from the subject.
- A male or female greater than or equal to sixty years of age, presenting with HZ at the time of enrollment.
- HZ diagnosis.
- Is the subject's first outpatient diagnosis for this HZ episode. OR
- Took place up to seven days prior to the initial visit for the present study. Note: Recurrent HZ cases may be enrolled as new cases based on the investigator's clinical practice.
Exclusion
- • Not applicable.
Key Trial Info
Start Date :
June 29 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 4 2015
Estimated Enrollment :
448 Patients enrolled
Trial Details
Trial ID
NCT01873365
Start Date
June 29 2013
End Date
February 4 2015
Last Update
June 1 2018
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Hokkaido, Japan, 084-0906
2
GSK Investigational Site
Hokkaido, Japan, 084-0909
3
GSK Investigational Site
Hokkaido, Japan, 084-0912
4
GSK Investigational Site
Hokkaido, Japan, 085-0014